Mesothelin has been reported to be a tumour-associated marker in several types of human cancers, including ovarian carcinomas and adenocarcinomas arising from the pancreatico-biliary tract, endometrium, and lungs[22]. Here, MSLN is linked to ovarian carcinoma.